AccScience Publishing / MI / Online First / DOI: 10.36922/mi.8358
Submit to MI
Cite this article
13
Download
299
Views
Journal Browser
Volume | Year
Issue
Search
Forthcoming Issue
Current Issue
View All
News and Announcements
View All
REVIEW ARTICLE

The role of Lactobacillus in combination with Bifidobacterium strains in mitigating obesity-related effects: A systematic review of studies in mice and humans

Krishnaraj Narayanan1 ,  Jz Kamille Eclarin1 ,  Alec Arbona1 ,  Nagendran Tharmalingam2,3*
Show Less
1 Department of Natural Science, College of Science and Technology, University of Houston-Downtown, Houston, Texas, United States of America
2 Department of Medicine, Houston Methodist Research Institute, Houston, Texas, United States of America
3 Department of Medicine, Weill Cornell Medical College, Cornell University, New York, United States of America
MI, 8358 https://doi.org/10.36922/mi.8358
Submitted: 1 January 2025 | Revised: 13 February 2025 | Accepted: 3 March 2025 | Published: 18 March 2025
© 2025 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
Download PDF
Cite
XML
Abstract

Body mass index (BMI) and waist circumference are regarded as early risk assessment factors for cardiometabolic comorbidities such as obesity, cardiovascular disease, and weight-related cancer. Specifically, obesity is a result of an imbalance of energy intake and expenditure and is usually determined by BMI. According to the Obesity Medicine Association Clinical Practice Statement, the adolescent obesity rate in the United States has drastically increased in the last 30 years affecting more than 20% adolescents. Addressing the rising rate of obesity has provided extensive research that suggests a strong link between gut microbiota phyla and the alleviation of obesity-related challenges. While a balanced lifestyle is the main recommendation to prevent and treat obesity, curative therapy is the goal. Research suggests that the human gut microbiota can help protect from pathogens, enhance the immune system, support digestion and metabolism, control epithelial cell proliferation and differentiation, modify insulin resistance and its secretion, and positively influence brain-gut communication This complex relationship suggests a strong link between gut microbiota and obesity-related effects. Microbiota imbalance is highly recognized as an indicator of a given disease or a poor health status. There are several probiotics that directly support the gut microbiota imbalance on obesity, including Lactobacillus (e.g., Lactobacillus casei, Lactobacillus gasseri, Lactobacillus rhamnosus, and Lactobacillus plantarum) and Bifidobacterium (e.g., Bifidobacterium infantis, Bifidobacterium longum, and Bifidobacterium breve B3). In this systematic review, we aim to consolidate existing evidence on the role of gut microbiota in managing obesity-related comorbidities, with a particular focus on the impact of specific probiotics on weight management and metabolic health. The review also provides an overview of the interplay between gut microbiota and obesity-related factors, including energy homeostasis, inflammation, and metabolic regulation.

Keywords
Lactobacillus
Bifidobacterium
Obesity
Systematic review
Funding
None.
Conflict of interest
The authors declare that there are no conflicts of interest.
References
  1. World Health Organization. Obesity and Overweight. World Health Organization; 2018. Available from: https:// www.who.int/news-room/fact-sheets/detail/obesity-and-overweight [Last accessed on 2018 Feb 16].

 

  1. Cuda S, O’Hara V, Censani M, et al. Special considerations for the adolescent with obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2024. Obes Pillars. 2024;9:100096. doi: 10.1016/j.obpill.2023.100096

 

  1. Abenavoli L, Scarpellini E, Colica C, et al. Gut microbiota and obesity: A role for probiotics. Nutrients. 2019;11(11):2690. doi: 10.3390/nu11112690

 

  1. Ben Othman R, Ben Amor N, Mahjoub F, et al. A clinical trial about effects of prebiotic and probiotic supplementation on weight loss, psychological profile and metabolic parameters in obese subjects. Endocrinol Diabetes Metab. 2023;6(2):e402. doi: 10.1002/edm2.402

 

  1. Shiu WC, Liu ZS, Chen BY, Ku YW, Chen PW. Evaluation of a standard dietary regimen combined with heat-inactivated Lactobacillus gasseri HM1, lactoferrin-producing HM1, and their sonication-inactivated variants in the management of metabolic disorders in an obesity mouse model. Foods. 2024;13(7):1079. doi: 10.3390/foods13071079

 

  1. Kurakawa T, Kani K, Chudan S, et al. Rice kefiran ameliorates obesity and hepatic steatosis through the change in gut microbiota. Microorganisms. 2024;12(12):2495. doi: 10.3390/microorganisms12122495

 

  1. Ramos MRZ, de Oliveira Carlos L, Wagner NRF, et al. Effects of Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 supplementation on nutritional and metabolic parameters in the early postoperative period after Roux-en-Y gastric bypass: A randomized, double-blind, placebo-controlled trial. Obes Surg. 2021;31:2105-2114. doi: 10.1007/s11695-021-05222-2

 

  1. Jang H, Joung H, Chu J, et al. Lactobacillus delbrueckii subsp. lactis CKDB001 ameliorates metabolic complications in high-fat diet-induced obese mice. Nutrients. 2024;16(24):4260. doi: 10.3390/nu16244260

 

  1. Rahayu ES, Mariyatun M, Manurung NEP, et al. Effect of probiotic Lactobacillus plantarum Dad-13 powder consumption on the gut microbiota and intestinal health of overweight adults. World J Gastroenterol. 2021;27(1):107-128. doi: 10.3748/wjg.v27.i1.107

 

  1. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement PLoS Med. 2009;6(7):e1000097. doi: 10.1371/journal.pmed.1000097

 

  1. Jang AR, Jung DH, Lee TS, et al. Lactobacillus plantarum NCHBL-004 modulates high-fat diet-induced weight gain and enhances GLP-1 production for blood glucose regulation. Nutrition. 2024;128:112565. doi: 10.1016/j.nut.2024.112565

 

  1. Jo YM, Son YJ, Kim SA, et al. Lactobacillus gasseri BNR17 and Limosilactobacillus fermentum ABF21069 ameliorate high sucrose-induced obesity and fatty liver via exopolysaccharide production and β-OXIDATION. J Microbiol. 2024;62:907-918. doi: 10.1007/s12275-024-00173-6

 

  1. Cai H, Wen Z, Li X, Meng K, Yang P. Lactobacillus plantarum FRT10 alleviated high-fat diet-induced obesity in mice through regulating the PPARα signal pathway and gut microbiota. Appl Microbiol Biotechnol. 2020;104:5959-5972. doi: 10.1007/s00253-020-10620-0

 

  1. Cai H, Wen Z, Zhao L, Yu D, Meng K, Yang P. Lactobacillus plantarum FRT4 alleviated obesity by modulating gut microbiota and liver metabolome in high-fat diet-induced obese mice. Food Nutr Res. 2022; 66:66. doi: 10.29219/fnr.v66.7974

 

  1. Zhu J, Liu X, Liu N, Zhao R, Wang S. Lactobacillus plantarum alleviates high-fat diet-induced obesity by altering the structure of mice intestinal microbial communities and serum metabolic profiles. Front Microbiol. 2024;15:1425764. doi: 10.3389/fmicb.2024.1425764

 

  1. Darwish AM, Mabrouk DM, Desouky HM, Khattab AEN. Evaluation of the effectiveness of two new strains of Lactobacillus on obesity-induced kidney diseases in BALB/c mice. J Genet Eng Biotechnol. 2022;20(1):148. doi: 10.1186/s43141-022-00427-z

 

  1. Gu Y, Bai J, Zhang J, et al. Transcriptomics reveals the anti-obesity mechanism of Lactobacillus plantarum fermented barley extract. Food Res Int. 2022;157:111285. doi: 10.1016/j.foodres.2022.111285

 

  1. He Q, Zhang Y, Ma D, Zhang W, Zhang H. Lactobacillus casei Zhang exerts anti-obesity effect to obese glut1 and gut-specific-glut1 knockout mice via gut microbiota modulation mediated different metagenomic pathways. Eur J Nutr. 2022;61(4):2003-2014. doi: 10.1007/s00394-021-02764-0

 

  1. Gong H, Gao H, Ren Q, He J. The abundance of Bifidobacterium in relation to visceral obesity and serum uric acid. Sci Rep. 2022;12(1):13073. doi: 10.1038/s41598-022-17417-3

 

  1. Kaczmarczyk M, Szulińska M, Łoniewski I, et al. Treatment with multi-species probiotics changes the functions, not the composition of gut microbiota in postmenopausal women with obesity: A randomized, double-blind, placebo-controlled study. Front Cell Infect Microbiol. 2022;12:815798. doi: 10.3389/fcimb.2022.815798

 

  1. Lauw S, Kei N, Chan PL, et al. Effects of synbiotic supplementation on metabolic syndrome traits and gut microbial profile among overweight and obese Hong Kong Chinese individuals: A randomized trial. Nutrients. 2023;15(19):4248. doi: 10.3390/nu15194248

 

  1. Michael D, Davies T, Jack A, et al. Daily supplementation with the Lab4P probiotic consortium induces significant weight loss in overweight adults. Sci Rep. 2021;11(1):5. doi: 10.1038/s41598-020-78285-3

 

  1. Kanazawa A, Aida M, Yoshida Y, et al. Effects of synbiotic supplementation on chronic inflammation and the gut microbiota in obese patients with type 2 diabetes mellitus: A randomized controlled study. Nutrients. 2021;13(2):558. doi: 10.3390/nu13020558

 

  1. Banach K, Glibowski P, Jedut P. The effect of probiotic yogurt containing Lactobacillus acidophilus LA-5 and Bifidobacterium lactis BB-12 on selected anthropometric parameters in obese individuals on an energy-restricted diet: A randomized, controlled trial. Appl Sci. 2020;10(17):5830. doi: 10.3390/app10175830

 

  1. Khan MN, Xie Z, Bukhari SMB, Nielsen DS, Imran M. Dairy-based multi-strain probiotic community successfully mitigated obesity-related gut microbiota dysbiosis in vitro (CoMiniGut). J Med Microbiol. 2024;73(11):001936. doi: 10.1099/jmm.0.001936

 

  1. Hawwash N, Sperrin M, Martin GP, et al. Waist circumference-years and cancer risk: A prospective study of the association and comparison of predictive performance with waist circumference and body mass index. Br J Cancer. 2024;131:1623-1634. doi: 10.1038/s41416-024-02860-y

 

  1. Pellegrini M, Ippolito M, Monge T, et al. Gut microbiota composition after diet and probiotics in overweight breast cancer survivors: A randomized open-label pilot intervention trial. Nutrition. 2020;74:110749. doi: 10.1016/j.nut.2020.110749

 

  1. Tremblay A, Fatani A, Ford AL, et al. Safety and effect of a low-and high-dose multi-strain probiotic supplement on microbiota in a general adult population: A randomized, double-blind, placebo-controlled study. J Diet Suppl. 2021;18(3):227-247. doi: 10.1080/19390211.2020.1749751

 

  1. Glasziou PP, Sanders SL. Investigating causes of heterogeneity in systematic reviews. Stat Med. 2002;21(11):1503-1511. doi: 10.1002/sim.1183

 

  1. Jucker M. The benefits and limitations of animal models for translational research in neurodegenerative diseases. Nat Med. 2010;16(11):1210-1214. doi: 10.1038/nm.2224

 

  1. Hackshaw A. Small studies: Strengths and limitations. Eur Respir J. 2008;32(5):1141-1143. doi: 10.1183/09031936.00136408

 

  1. McFarland LV, Evans CT, Goldstein EJC. Strain-specificity and disease-specificity of probiotic efficacy: A systematic review and meta-analysis. Front Med (Lausanne). 2018;5:124. doi: 10.3389/fmed.2018.00124

 

  1. Herle M, Smith AD, Kininmonth A, Llewellyn C. The role of eating behaviours in genetic susceptibility to obesity. Curr Obes Rep. 2020;9(4):512-521. doi: 10.1007/s13679-020-00402-0

 

Share
Back to top
Microbes & Immunity, Electronic ISSN: 3029-2883 Print ISSN: 3041-0886, Published by AccScience Publishing
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here
Accept